Land: Irland
Språk: engelska
Källa: HPRA (Health Products Regulatory Authority)
Isoleucine; Leucine; Lysine acetate; Methionine; Phenylalanine; Threonine; Tryptophan; Valine; Arginine; Histidine; Alanine; Glycine; Proline; Serine; Tyrosine; Taurine
Fresenius Kabi Limited
B05BA; B05BA01
Isoleucine; Leucine; Lysine acetate; Methionine; Phenylalanine; Threonine; Tryptophan; Valine; Arginine; Histidine; Alanine; Glycine; Proline; Serine; Tyrosine; Taurine
5 gram(s)/litre
Solution for infusion
Product subject to prescription which may not be renewed (A)
Solutions for parenteral nutrition; amino acids
Not marketed
1999-09-07
PACKAGE LEAFLET: INFORMATION FOR THE USER AMINOVEN ® 8 SOLUTION FOR INFUSION AMINOVEN ® 16 SOLUTION FOR INFUSION AMINOVEN ® 25 SOLUTION FOR INFUSION READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor, pharmacist or nurse. - If you get any of the side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Aminoven is and what it is used for 2. What you need to know before you receive Aminoven 3. How to use Aminoven 4. Possible side effects 5. How to store Aminoven 6. Contents of the pack and other information 1. WHAT AMINOVEN IS AND WHAT IT IS USED FOR Aminoven provides nourishment straight into your blood stream when you cannot eat normally. It provides amino acids which your body will use to make proteins (to build and repair muscles, organs, and other body structures). Aminoven is typically mixed in a pharmacy with fat, carbohydrates, salts and vitamins, which together provide your complete nutritional needs. This leaflet covers 3 products: • Aminoven 8 Solution for Infusion • Aminoven 16 Solution for Infusion • Aminoven 25 Solution for Infusion In this leaflet the three solutions are collectively referred to as Aminoven. 2. WHAT YOU NEED TO KNOW BEFORE YOU RECEIVE AMINOVEN YOU SHOULD NOT RECEIVE AMINOVEN IF YOU ARE SUFFERING FROM, OR HAVE SUFFERED FROM THE FOLLOWING.: DO NOT USE AMINOVEN: • if you have a condition where your BODY HAS PROBLEMS USING PROTEINS OR AMINO ACIDS • if you have METABOLIC ACIDOSIS (the acid levels of your body fluids and tissues become too high) • if you have reduced KIDNEY function and are not on dialysis or another form of blood filtration treatment • if you have seriously reduced LIVER FUNCTION • inf you have FLUID RETENTION • if you suffer from SHOCK • if you have HYPOXIA (low Läs hela dokumentet
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Aminoven 8, solution for infusion, bottle 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1000 ml solution for infusion contain: Isoleucine 2. 50 g Leucine 3. 70 g Lysine acetate 4. 655 g = Lysine 3.30 g Methionine 2. 15 g Phenylalanine 2. 55 g Threonine 2. 20 g Tryptophan 1. 00 g Valine 3. 10 g Arginine 6. 00 g Histidine 1. 50 g Alanine 7. 00 g Glycine 5. 50 g Proline 5. 60 g Serine 3. 25 g Tyrosine 0. 20 g Taurine 0. 50 g Total amino acids: 50.0 g/l Total nitrogen: 8.1 g/l Total energy: 840 kJ/l (= 200kcal/l) Titratable acidity : 12 mmol NaOH/l 3 PHARMACEUTICAL FORM Solution for infusion The solution is clear and colourless to slightly yellow pH: 5.5 - 6.3 Theoretical osmolarity: 495 mosm/l 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For supply of amino acids as part of a parenteral nutrition regimen. Amino acid solutions should be administered generally in combination with adequate amount of energy supplements. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _2_ _1_ _/_ _0_ _8_ _/_ _2_ _0_ _1_ _8_ _C_ _R_ _N_ _ _ _2_ _2_ _0_ _6_ _0_ _3_ _9_ _p_ _a_ _g_ _e_ _ _ _n_ _u_ _m_ _b_ _e_ _r_ _:_ _ _ _1_ 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology The daily requirement of amino acids depends on the body weight and the metabolic conditions of the patient. The maximum daily dose varies with the clinical condition of the patient and may even change from day to day. The recommended infusion period is to provide a con Läs hela dokumentet